Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer

Gynecologic Oncology

Volumn 123, Issue 2, 2011, Pages 208-213

  Garg, Gunjal ^a   Morris, Robert T ^a,b   Solomon, Leigh ^a,b   Toy, Eugene P ^c   Kruger, Michael ^a   Clary, Karen ^d   Munkarah, Adnan ^e   Wright, Jason D ^f  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d ROCHESTER GENERAL HOSPITAL   (United States)

^e HENRY FORD HOSPITAL   (United States)

^f Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Endometrial cancer; Extrauterine disease; Para aortic lymph nodes; Pelvic lymph nodes; Stage IIIC

Indexed keywords

ADNEXA DISEASE; ADNEXA METASASIS; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CYTOLOGY; DISEASE SEVERITY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PERITONEUM; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; VAGINA DISEASE; VAGINA METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM;

EID: 80054721174     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.07.025     Document Type: Article

References (22)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 1987 2035 2041
3. C.P. Morrow, B.N. Bundy, R.J. Kurman, W.T. Creasman, P. Heller, and H.D. Homesley Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol Oncol 40 1991 55 65
4. D.S. McMeekin, D. Lashbrook, M. Gold, G. Johnson, J.L. Walker, and R. Mannel Analysis of FIGO stage IIIc endometrial cancer patients Gynecol Oncol 81 2001 273 278
5. K.M. Greven, R.M. Lanciano, B. Corn, D. Case, and M.E. Randall Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence Cancer 71 1993 3697 3702
6. A. Mariani, M.J. Webb, G.L. Keeney, M.G. Haddock, G. Aletti, and K.C. Podratz Stage IIIC endometrioid corpus cancer includes distinct subgroups Gynecol Oncol 87 2002 112 117
7. H.S. Kim, and Y.S. Song International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer? J Gynecol Oncol 20 2009 135 136
8. Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2008 Sub (1973-2006 varying) - Linked To County Attributes - Total U.S., 1969-2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
9. K. Hirahatake, H. Hareyama, N. Sakuragi, M. Nishiya, S. Makinoda, and S. Fujimoto A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma J Surg Oncol 65 1997 82 87
10. H. Watari, Y. Todo, M. Takeda, Y. Ebina, R. Yamamoto, and N. Sakuragi Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer Gynecol Oncol 96 2005 651 657
11. A.V. Hoekstra, R.J. Kim, W. Small Jr. , A.W. Rademaker, I.B. Helenowski, and D.K. Singh FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes Gynecol Oncol 114 2009 273 278
12. N. Kadar, H.D. Homesley, and J.H. Malfetano Prognostic factors in surgical stage III and IV carcinoma of the endometrium Obstet Gynecol 84 1994 983 986
13. S.N. Lewin, T.J. Herzog, N.I. Barrena Medel, I. Deutsch, W.M. Burke, X. Sun, and J.D. Wright Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer Obstet Gynecol 116 2010 1141 1149
14. G. Nelson, M. Randall, G. Sutton, D. Moore, J. Hurteau, and K. Look FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy Gynecol Oncol 75 1999 211 214
15. A.H. Klopp, A. Jhingran, L. Ramondetta, K. Lu, D.M. Gershenson, and P.J. Eifel Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation Gynecol Oncol 115 2009 6 11
16. N.I. Barrena Medel, T.J. Herzog, I. Deutsch, W.M. Burke, X. Sun, and S.N. Lewin Comparison of the prognostic significance of uterine factors and nodal status for endometrial cancer Am J Obstet Gynecol 204 248 2011 e1 e7
17. M.E. Randall, V.L. Filiaci, H. Muss, N.M. Spirtos, R.S. Mannel, and J. Fowler Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 24 2006 36 44
18. A.J. Mundt, K.T. Murphy, J. Rotmensch, S.E. Waggoner, S.D. Yamada, and P.P. Connell Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma Int J Radiat Oncol Biol Phys 50 2001 1154 1160
19. T. Onda, H. Yoshikawa, K. Mizutani, M. Mishima, H. Yokota, and H. Nagano Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy Br J Cancer 75 1997 1836 1841
20. M. Bruzzone, L. Miglietta, P. Franzone, A. Gadducci, and F. Boccardo Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients Gynecol Oncol 93 2004 345 352
21. P.J. Hoskins, K.D. Swenerton, J.A. Pike, F. Wong, P. Lim, and C. Acquino-Parsons Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study J Clin Oncol 19 2001 4048 4053
22. J.O. Schorge, K.L. Molpus, A. Goodman, N. Nikrui, and A.F. Fuller Jr. The effect of postsurgical therapy on stage III endometrial carcinoma Gynecol Oncol 63 1996 34 39